<![CDATA[HistoSonics 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=44141>Mon, 27 Jul 2026 21:07:13 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[히스토소닉스, 홍콩 히스토트립시 교육센터 확장 개소]]>https://www.newswire.co.kr/newsRead.php?no=1038991Tue, 21 Jul 2026 13:30:00 +0900<![CDATA[HistoSonics Opens Expanded Histotripsy Training Center in Hong Kong]]>https://www.newswire.co.kr/newsRead.php?no=1038992Tue, 21 Jul 2026 13:30:00 +0900<![CDATA[HistoSonics Receives CE Mark, Unlocking Access Across Europe and Accelerating Global Commercialization of the Edison® Histotripsy Platform]]>https://www.newswire.co.kr/newsRead.php?no=1038760Thu, 16 Jul 2026 13:30:00 +0900<![CDATA[히스토소닉스, 에디슨® 시스템 CE 마크 획득… 유럽 전역 접근성 확보 및 히스토트립시 플랫폼 글로벌 상용화 가속화]]>https://www.newswire.co.kr/newsRead.php?no=1038761Thu, 16 Jul 2026 13:30:00 +0900<![CDATA[HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors]]>https://www.newswire.co.kr/newsRead.php?no=1037150Tue, 23 Jun 2026 11:30:00 +0900<![CDATA[히스토소닉스, 요세미티 등 전략적 투자자들의 참여로 자금 조달 발표]]>https://www.newswire.co.kr/newsRead.php?no=1037151Tue, 23 Jun 2026 11:30:00 +0900<![CDATA[HistoSonics Receives Landmark TFDA Approval in Taiwan, Accelerating Global Expansion]]>https://www.newswire.co.kr/newsRead.php?no=1035059Fri, 22 May 2026 15:30:00 +0900<![CDATA[히스토소닉스, 대만 TFDA의 기념비적 승인 획득으로 글로벌 확장 가속화]]>https://www.newswire.co.kr/newsRead.php?no=1035064Fri, 22 May 2026 15:30:00 +0900<![CDATA[HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors]]>https://www.newswire.co.kr/newsRead.php?no=1034253Tue, 12 May 2026 14:30:00 +0900<![CDATA[히스토소닉스, 신장 종양 대상 FDA 신청 발표… 히스토트립시 적용 확대 추진]]>https://www.newswire.co.kr/newsRead.php?no=1034257Tue, 12 May 2026 14:30:00 +0900<![CDATA[HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)]]>https://www.newswire.co.kr/newsRead.php?no=1031371Tue, 31 Mar 2026 09:50:00 +0900<![CDATA[히스토소닉스, 양성 전립선 비대증 치료 위한 에디슨 히스토트립시 시스템 임상 첫 환자 치료 성공]]>https://www.newswire.co.kr/newsRead.php?no=1031377Tue, 31 Mar 2026 09:50:00 +0900<![CDATA[HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members]]>https://www.newswire.co.kr/newsRead.php?no=1021212Thu, 23 Oct 2025 11:40:00 +0900<![CDATA[히스토소닉스, 비침습 간종양 치료 보험 적용 대상을 엘리번스 헬스 회원 4540만 명으로 확대]]>https://www.newswire.co.kr/newsRead.php?no=1021213Thu, 23 Oct 2025 11:40:00 +0900<![CDATA[HistoSonics Announces Oversubscribed $250 Million Growth Financing]]>https://www.newswire.co.kr/newsRead.php?no=1020839Fri, 17 Oct 2025 14:50:00 +0900<![CDATA[히스토소닉스, 2억5000만달러 규모 성장 자금 초과 모집 마감 발표]]>https://www.newswire.co.kr/newsRead.php?no=1020840Fri, 17 Oct 2025 14:50:00 +0900<![CDATA[HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors]]>https://www.newswire.co.kr/newsRead.php?no=1016380Fri, 08 Aug 2025 11:20:00 +0900<![CDATA[히스토소닉스, 22억5000만달러 가치로 탑티어 투자자 컨소시엄의 과반수 지분 인수 완료 발표]]>https://www.newswire.co.kr/newsRead.php?no=1016383Fri, 08 Aug 2025 11:20:00 +0900<![CDATA[HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Blue Cross Blue Shield Highmark Members]]>https://www.newswire.co.kr/newsRead.php?no=1014963Tue, 15 Jul 2025 14:50:00 +0900<![CDATA[히스토소닉스, 비침습적 간 종양 치료에 대한 보험 적용 범위를 블루 크로스 블루 쉴드 하이마크 회원 700만 명으로 확대]]>https://www.newswire.co.kr/newsRead.php?no=1014964Tue, 15 Jul 2025 14:50:00 +0900<![CDATA[HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift]]>https://www.newswire.co.kr/newsRead.php?no=1012882Wed, 11 Jun 2025 12:05:00 +0900<![CDATA[히스토소닉스-케임브리지 대학, 리카싱 재단 기부로 유럽 최초 ‘Edison™ 히스토트립시 시스템’ 선보여]]>https://www.newswire.co.kr/newsRead.php?no=1012884Wed, 11 Jun 2025 12:05:00 +0900<![CDATA[HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors]]>https://www.newswire.co.kr/newsRead.php?no=1012655Sun, 08 Jun 2025 13:10:00 +0900<![CDATA[히스토소닉스, 신장 종양 치료를 위한 비침습적 히스토트립시를 평가하는 #HOPE4KIDNEY 임상시험의 환자 등록 완료]]>https://www.newswire.co.kr/newsRead.php?no=1012656Sun, 08 Jun 2025 13:10:00 +0900<![CDATA[HistoSonics’ Edison Histotripsy System Gains Great Britain Early Market Access Under Unmet Clinical Needs Authorisation]]>https://www.newswire.co.kr/newsRead.php?no=1012304Sun, 01 Jun 2025 10:30:00 +0900